Effects of the antioxidant Pycnogenol® on cellular redox systems in U1285 human lung carcinoma cells

FEBS Journal

Volumn 276, Issue 2, 2009, Pages 532-540

  Gandin, Valentina ^a,d   Nyström, Christina ^a   Rundlöf, Anna Klara ^a   Jönsson Videsäter, Kerstin ^a   Schönlau, Frank ^b   Hörkkö, Jarmo ^c   Björnstedt, Mikael ^a   Fernandes, Aristi P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Almado   (Finland)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antioxidant; Glutathione peroxidise; Oxidative stress; Pycnogenol ; Thioredoxin reductase

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; MESSENGER RNA; OXIDOREDUCTASE; PYCNOGENOL; REACTIVE OXYGEN METABOLITE; SELENITE; THIOREDOXIN REDUCTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIOXIDANTS; CELL SURVIVAL; ENZYME ACTIVATION; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAREDOXINS; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SODIUM SELENITE; THIOREDOXIN-DISULFIDE REDUCTASE; TIME FACTORS;

PINUS PINASTER;

EID: 58149161826     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06800.x     Document Type: Article

References (40)

1. Nordberg J Arnér ES (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31, 1287 1312.
2. Rohdewald P (2002) A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40, 158 168.
3. Packer L, Rimbach G Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27, 704 724.
4. Rohdewald P (2005) Pycnogenol® protects DNA against oxidative damage in vivo. Phytother Res 19, 262.
5. Spadea L Balestrazzi E (2001) Treatment of vascular retinopathies with Pycnogenol®. Phytother Res 15, 219 223.
6. Liu X, Wei J, Tan F, Zhou S, Wurthwein G Rohdewald P (2004) Pycnogenol®, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci 74, 855 862.
7. Liu X, Zhou HJ Rohdewald P (2004) French maritime pine bark extract Pycnogenol® dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 27, 839.
8. Papp LV, Lu J, Holmgren A Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9, 775 806.
9. Björnstedt M, Hamberg M, Kumar S, Xue J Holmgren A (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 270, 11761 11764.
10. Gladyshev VN Kryukov GV (2001) Evolution of selenocysteine-containing proteins: significance of identification and functional characterization of selenoproteins. Biofactors 14, 87 92.
11. Arnér ES Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267, 6102 6109.
12. Björnstedt M, Kumar S, Björkhem L, Spyrou G Holmgren A (1997) Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci 10, 271 279.
13. Xia L, Nordman T, Olsson JM, Damdimopoulos A, Björkhem-Bergman L, Nalvarte I, Eriksson LC, Arnér ES, Spyrou G Björnstedt M (2003) The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J Biol Chem 278, 2141 2146.
14. Gladyshev VN, Jeang KT Stadtman TC (1996) Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci USA 93, 6146 6151.
15. Tamura T Stadtman TC (1996) A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93, 1006 1011.
16. Zhong L, Arnér ES, Ljung J, Aslund F Holmgren A (1998) Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 273, 8581 8591.
17. Zhong L Holmgren A (2000) Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 275, 18121 18128.
18. Holmgren A (1977) Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J Biol Chem 252, 4600 4606.
19. Spyrou G, Enmark E, Miranda-Vizuete A Gustafsson J (1997) Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272, 2936 2941.
20. Damdimopoulos AE, Miranda-Vizuete A, Treuter E, Gustafsson JA Spyrou G (2004) An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem 279, 38721 38729.
21. Sun QA, Zappacosta F, Factor VM, Wirth PJ, Hatfield DL Gladyshev VN (2001) Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276, 3106 3114.
22. Lescure A, Gautheret D, Carbon P Krol A (1999) Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J Biol Chem 274, 38147 38154.
23. Gromer S, Urig S Becker K (2004) The thioredoxin system - from science to clinic. Med Res Rev 24, 40 89.
24. Powis G Kirkpatrick DL (2007) Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol 7, 392 397.
25. Urig S Becker K (2006) On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol 16, 452 465.
26. Nguyen P, Awwad RT, Smart DD, Spitz DR Gius D (2006) Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Lett 236, 164 174.
27. Spyrou G, Björnstedt M, Skog S Holmgren A (1996) Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res 56, 4407 4412.
28. Arnér ES, Nordberg J Holmgren A (1996) Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 225, 268 274.
29. Kumar S, Björnstedt M Holmgren A (1992) Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 207, 435 439.
30. Björnstedt M, Kumar S Holmgren A (1992) Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem 267, 8030 8034.
31. Reeves PG, Leary PD, Gregoire BR, Finley JW, Lindlauf JE Johnson LK (2005) Selenium bioavailability from buckwheat bran in rats fed a modified AIN-93G torula yeast-based diet. J Nutr 135, 2627 2633.
32. Berry MJ (2005) Insights into the hierarchy of selenium incorporation. Nat Genet 37, 1162 1163.
33. Suzuki KT, Doi C Suzuki N (2006) Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite. Toxicol Appl Pharmacol 217, 185 195.
34. Hintze KJ, Wald KA, Zeng H, Jeffery EH Finley JW (2003) Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J Nutr 133, 2721 2727.
35. Becker K, Gromer S, Schirmer RH Muller S (2000) Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267, 6118 6125.
36. Björkhem-Bergman L, Jonsson K, Eriksson LC, Olsson JM, Lehmann S, Paul C Björnstedt M (2002) Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase. Biochem Pharmacol 63, 1875 1884.
37. Gornall AG, Bardawill CJ David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177, 751 766.
38. Holmgren A Björnstedt M (1995) Thioredoxin and thioredoxin reductase. Methods Enzymol 252, 199 208.
39. Lawrence RA Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71, 952 958.
40. Rundlöf AK, Fernandes AP, Selenius M, Babic M, Shariatgorji M, Nilsonne G, Ilag LL, Dobra K Björnstedt M (2007) Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. Differentiation 75, 123 132.